Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 116, Issue 17, Pages 8463-8470
Publisher
Proceedings of the National Academy of Sciences
Online
2019-04-09
DOI
10.1073/pnas.1820039116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
- (2018) Barbara Willekens et al. CNS DRUGS
- Predictors of vision impairment in Multiple Sclerosis
- (2018) Bernardo Sanchez-Dalmau et al. PLoS One
- Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
- (2018) Georgina Flórez-Grau et al. Frontiers in Immunology
- Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
- (2018) Eros Marín et al. Frontiers in Immunology
- Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease
- (2017) Brett Eugene Phillips et al. Frontiers in Immunology
- Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
- (2016) G M Bell et al. ANNALS OF THE RHEUMATIC DISEASES
- Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases
- (2016) Paulina García-González et al. AUTOIMMUNITY REVIEWS
- Selective depletion of CD11c+CD11b+dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE
- (2016) Limei Wang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Norovirus-Specific Memory T Cell Responses in Adult Human Donors
- (2016) Maria Malm et al. Frontiers in Microbiology
- Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies
- (2016) Phillip Lord et al. PeerJ
- Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn’s Disease: A Phase I Study
- (2015) Aranzazu Jauregui-Amezaga et al. Journal of Crohns & Colitis
- MERTK as negative regulator of human T cell activation
- (2015) Raquel Cabezo´n et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The re-emergence of antigen-specific tolerance as a potential therapy for MS
- (2015) Lawrence Steinman Multiple Sclerosis Journal
- Challenges and opportunities in designing clinical trials for neuromyelitis optica
- (2015) B. G. Weinshenker et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients
- (2015) Helen Benham et al. Science Translational Medicine
- The re-emergence of antigen-specific tolerance as a potential therapy for MS
- (2015) Lawrence Steinman Multiple Sclerosis Journal
- Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
- (2015) Johannes M. van Noort et al. PLoS One
- Autoimmunity and tumor immunology: two facets of a probabilistic immune system
- (2014) Jaime Iranzo et al. BMC Systems Biology
- Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis
- (2014) María José Mansilla et al. CNS Neuroscience & Therapeutics
- Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
- (2013) Ilse Van Brussel et al. AUTOIMMUNITY REVIEWS
- Regulatory dendritic cell therapy: From rodents to clinical application
- (2013) Dalia Raïch-Regué et al. IMMUNOLOGY LETTERS
- Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
- (2013) A. Lutterotti et al. Science Translational Medicine
- Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognizeClostridiumABC transporter
- (2012) Michel Varrin-Doyer et al. ANNALS OF NEUROLOGY
- Human Aquaporin 4281-300Is the Immunodominant Linear Determinant in the Context of HLA-DRB1*03:01
- (2012) Benjamine Arellano et al. ARCHIVES OF NEUROLOGY
- Gram-Negative Enterobacteria Induce Tolerogenic Maturation in Dexamethasone Conditioned Dendritic Cells
- (2012) Raquel Cabezón et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
- (2011) N. Giannoukakis et al. DIABETES CARE
- Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica
- (2011) N. Matsuya et al. INTERNATIONAL IMMUNOLOGY
- Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway
- (2010) S. Gregori et al. BLOOD
- Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis
- (2010) L. Grau-López et al. EUROPEAN JOURNAL OF NEUROLOGY
- Induction of Treg by monocyte-derived DC modulated by vitamin D3or dexamethasone: Differential role for PD-L1
- (2009) Wendy W. J. Unger et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-10 suppressor activity andex vivo Tr1 cell function are impaired in multiple sclerosis
- (2008) Ivan Martinez-Forero et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More